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Bioprosthetic heart valve dysfunction resulting from deteri-
oration of its supportive stent is uncommon. Permanent inward
deformation of the stent posts (“stent creep”), a phenomenon
known to occur in some bioprosthetic models as the result of
valve oversizing, may lead to intrinsic valve stenosis.1 However,
total disruption of the stent leading to valve dysfunction is rare,
with only few reports being available in the literature. 
Clinical summary. We report the case of a 55-year-old
man who underwent mitral valve replacement with a size 33
mm Carpentier-Edwards supra-annular porcine bioprosthesis
(Baxter Healthcare Corp, Edwards Division, Santa Ana,
Calif) for rheumatic heart valve disease in 1987. Apart from
this, his medical history revealed no other relevant data. He
remained free of symptoms until October 1997, when he
started having shortness of breath. In December 1997 he was
admitted to our hospital on an emergency basis with grade IV
dyspnea and peripheral edema. A chest x-ray film showed a
pattern of pulmonary edema and a double fracture in the wire
stent of the mitral prosthesis (Fig 1). Echocardiography
revealed moderate regurgitation of the aortic valve, mitral
prosthesis, and tricuspid valve. Cardiac catheterization con-
firmed these findings and demonstrated moderate impairment
of left ventricular function, as well as a pulmonary artery
pressure of 107/50 mm Hg (mean 69 mm Hg). He was ini-
tially treated with captopril and diuretics with good response,
and surgery was indicated. The patient underwent mitral and
aortic valve replacement with St Jude Medical mechanical
devices (sizes 33 mm and 25 mm, respectively; St Jude
Medical, Inc, St Paul, Minn) and tricuspid annuloplasty. The
macroscopic examination of the explanted mitral bioprosthe-
sis disclosed moderate tissue mineralization and a severe
inward deformity of one of its stent posts, causing the pro-
lapse of an adjacent cusp (Fig 2). His postoperative course
was complicated by postperfusion vasoplegic shock unre-
sponsive to treatment, resulting in rapidly progressing multi-
organ failure that led to his death in the intensive care unit on
the second postoperative day.
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Fig 1. Detailed view of the pre-explantation lateral chest radiograph showing two fractures (arrows) in the wire
frame of the mitral bioprosthesis.
Discussion. Stent disruption is an extraordinarily uncom-
mon mode of structural deterioration in bioprosthetic heart
valve substitutes. For this reason, the data available in the lit-
erature on this subject are very limited. The compliant metal
frame of Carpentier-Edwards bioprostheses is manufactured
with Elgiloy, a corrosion-resistant alloy of cobalt and nickel
(Elgiloy Limited Partnership, Elgin, Ill) that was chosen for
its spring efficiency and its fatigue-resistant characteristics.
To our knowledge, only one case of a mitral Carpentier-
Edwards bioprosthesis malfunctioning as the result of frac-
turing of its Elgiloy wire frame has been previously reported.2
Most of the data available on this complication refer to the
experience achieved with the Wessex porcine bioprosthe-
sis,3-5 a device no longer available for clinical use, in which
the fracture of the acetyl copolymer stent was a common
mode of deterioration.5
The mechanisms responsible for the occurrence of such
fractures, which are often multiple in the affected devices,5
are uncertain. Computer-based studies on the Delrin stent of
Hancock II porcine bioprostheses (Medtronic, Inc,
Minneapolis, Minn) have identified the bases of the commis-
sural arches of the frame as areas supporting high mechanical
stresses.6 Fractures have a tendency to occur in these particu-
lar areas2-5 and, on these grounds, one can speculate that this
phenomenon could be due to mechanical fatigue of the stent
materials in areas of increased stress. This theory would also
be supported by the fact that clinically relevant stent fractures
are more common in valves implanted in the mitral position
(where prosthetic frames must withstand greater static and
dynamic stresses owing to the physiologic tridimensional
dynamics of the native mitral anulus) than in those implanted
at other sites.2-5
Clinical presentation is in the form of valve regurgita-
tion2-5 which, in our patient, occurred in a subacute manner
11 years after implantation. However, the reported experi-
ence with explanted Wessex bioprostheses5 suggests that
valves with fewer than two fractures (as often occurs with
devices implanted in the aortic position) have only a modest
risk of deformation. In these cases, the valves may be func-
tioning normally and, thus, the ruptured stent may be unno-
ticed by the observing physician and even by the explanting
surgeon.
Clinical screening of fractures in the wire stent of
Carpentier-Edwards bioprostheses is simple because their
metal radiopaque frame can be easily visualized with a con-
ventional chest radiograph, as illustrated by Fig 1. However,
the detection of such complication in patients having bio-
prosthetic devices with radiolucent frames may be more dif-
ficult. Echocardiography would probably be the diagnostic
method of choice in these cases.
We believe that conservative management with a close fol-
low-up is probably the best line of action so long as the valve
continues to function normally. However, if a serious defor-
mity of the device is observed, particularly if there is any
clinical evidence of valve dysfunction, replacement surgery
should be considered.
R E F E R E N C E S
1. Schoen FJ, Schulman LJ, Cohn LH. Quantitative anatomic analy-
sis of “stent creep” of explanted Hancock standard porcine bio-
prostheses used for cardiac valve replacement. Am J Cardiol
1985;56:110-4.
2. Griffin S, Bouboulis N, Holden MP. Fracture of the wire stent in
a Carpentier-Edwards porcine bioprosthesis. J Heart Valve Dis
1993;2:357-8.
198 Brief communications The Journal of Thoracic and
Cardiovascular Surgery
July 1999
Fig 2. Explanted bioprosthesis. A notorious inward deformity in one of its stent posts with protrusion of the frac-
tured wire can be observed (arrow).
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